Imago BioSciences, Inc. Shareholders' Equity
Imago BioSciences, Inc. had Shareholders' Equity of $172.62 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-11-09
- 2022-09-30: Stockholders' Equity Attributable to Parent $172.62M.
- 2022-06-30: Stockholders' Equity Attributable to Parent $187.34M.
- 2022-03-31: Stockholders' Equity Attributable to Parent $199.51M.
- 2021-12-31: Stockholders' Equity Attributable to Parent $214.69M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2022-09-30 | $172.62M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $187.34M 10-Q · filed 2022-11-09 |
| 2022-03-31 | $199.51M 10-Q · filed 2022-11-09 |
| 2021-12-31 | $214.69M 10-Q · filed 2022-11-09 |
| 2021-09-30 | $228.36M 10-Q · filed 2022-11-09 |
| 2021-06-30 | -$83.82M 10-Q · filed 2022-11-09 |
| 2021-03-31 | -$75.56M 10-Q · filed 2022-11-09 |
| 2020-12-31 | -$68.78M 10-Q · filed 2022-11-09 |
| 2020-09-30 | -$63.39M 10-Q · filed 2021-11-10 |
| 2020-06-30 | -$59.19M 10-Q · filed 2021-11-10 |
| 2020-03-31 | -$55.55M 10-Q · filed 2021-11-10 |
| 2019-12-31 | -$51.40M 10-K · filed 2022-03-24 |